Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.507ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.507ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.507NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.196ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.196ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.196ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.196NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.459ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.459ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.459ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.459NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.117ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.117ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.117ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.117NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.381ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.381ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.381NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.237ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.237ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.237ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.237NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.382ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.382ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.382NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.395ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.395ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.395NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used